Mark Ferguson to Precision Medicine
This is a "connection" page, showing publications Mark Ferguson has written about Precision Medicine.
Connection Strength
0.098
-
Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation. Oncotarget. 2016 Apr 05; 7(14):18876-86.
Score: 0.098